Wnt to market

How Samumed and its investors justify its $12 billion private valuation

With no traditional life science VCs in its syndicate and little publicly disclosed about its science, Samumed LLC was able to raise a $438 million round at a premoney valuation of $12 billion, bringing its total funding to more than $650 million to date.

The company hasn’t yet described any of its Wnt signaling pathway modulators’ mechanisms or targets, but

Read the full 590 word article

User Sign In